CAMECO CORP (CCJ)

CA13321L1085 - Common Stock

49.35  +0.19 (+0.39%)

After market: 49.49 +0.14 (+0.28%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CCJ. CCJ was compared to 214 industry peers in the Oil, Gas & Consumable Fuels industry. While CCJ seems to be doing ok healthwise, there are quite some concerns on its profitability. CCJ is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year CCJ was profitable.
In the past year CCJ had a positive cash flow from operations.
In multiple years CCJ reported negative net income over the last 5 years.
In the past 5 years CCJ always reported a positive cash flow from operatings.

1.2 Ratios

CCJ has a worse Return On Assets (3.63%) than 66.67% of its industry peers.
With a Return On Equity value of 5.92%, CCJ is not doing good in the industry: 72.30% of the companies in the same industry are doing better.
The Return On Invested Capital of CCJ (2.41%) is worse than 78.87% of its industry peers.
Industry RankSector Rank
ROA 3.63%
ROE 5.92%
ROIC 2.41%
ROA(3y)1.1%
ROA(5y)0.72%
ROE(3y)1.78%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CCJ's Profit Margin of 13.94% is in line compared to the rest of the industry. CCJ outperforms 47.89% of its industry peers.
CCJ's Profit Margin has improved in the last couple of years.
CCJ has a Operating Margin of 11.02%. This is in the lower half of the industry: CCJ underperforms 69.95% of its industry peers.
CCJ's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 21.70%, CCJ is doing worse than 68.08% of the companies in the same industry.
CCJ's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.02%
PM (TTM) 13.94%
GM 21.7%
OM growth 3YN/A
OM growth 5Y26.02%
PM growth 3YN/A
PM growth 5Y11.89%
GM growth 3Y54.28%
GM growth 5Y8.95%

5

2. Health

2.1 Basic Checks

CCJ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CCJ has been increased compared to 1 year ago.
The number of shares outstanding for CCJ has been increased compared to 5 years ago.
CCJ has a worse debt/assets ratio than last year.

2.2 Solvency

CCJ has an Altman-Z score of 5.42. This indicates that CCJ is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CCJ (5.42) is better than 90.61% of its industry peers.
CCJ has a debt to FCF ratio of 3.34. This is a good value and a sign of high solvency as CCJ would need 3.34 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.34, CCJ is in the better half of the industry, outperforming 65.26% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that CCJ is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.21, CCJ is doing good in the industry, outperforming 67.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 3.34
Altman-Z 5.42
ROIC/WACC0.31
WACC7.82%

2.3 Liquidity

CCJ has a Current Ratio of 1.55. This is a normal value and indicates that CCJ is financially healthy and should not expect problems in meeting its short term obligations.
CCJ has a Current ratio of 1.55. This is in the better half of the industry: CCJ outperforms 67.14% of its industry peers.
A Quick Ratio of 0.97 indicates that CCJ may have some problems paying its short term obligations.
CCJ's Quick ratio of 0.97 is in line compared to the rest of the industry. CCJ outperforms 47.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.97

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 132.35% over the past year.
The Earnings Per Share has been growing slightly by 7.91% on average over the past years.
CCJ shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.53%.
The Revenue has been growing slightly by 4.35% on average over the past years.
EPS 1Y (TTM)132.35%
EPS 3YN/A
EPS 5Y7.91%
EPS growth Q2Q133.33%
Revenue 1Y (TTM)38.53%
Revenue growth 3Y12.86%
Revenue growth 5Y4.35%
Revenue growth Q2Q61.1%

3.2 Future

CCJ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.85% yearly.
CCJ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.49% yearly.
EPS Next Y80.91%
EPS Next 2Y52.54%
EPS Next 3Y42.39%
EPS Next 5Y9.85%
Revenue Next Year17.76%
Revenue Next 2Y11.06%
Revenue Next 3Y8.86%
Revenue Next 5Y5.49%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 85.09 indicates a quite expensive valuation of CCJ.
81.22% of the companies in the same industry are cheaper than CCJ, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CCJ to the average of the S&P500 Index (25.20), we can say CCJ is valued expensively.
A Price/Forward Earnings ratio of 47.22 indicates a quite expensive valuation of CCJ.
Based on the Price/Forward Earnings ratio, CCJ is valued a bit more expensive than the industry average as 69.95% of the companies are valued more cheaply.
CCJ is valuated expensively when we compare the Price/Forward Earnings ratio to 21.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 85.09
Fwd PE 47.22

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCJ is valued a bit more expensive than the industry average as 77.46% of the companies are valued more cheaply.
65.73% of the companies in the same industry are cheaper than CCJ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 54.82
EV/EBITDA 60.17

4.3 Compensation for Growth

CCJ's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CCJ's earnings are expected to grow with 42.39% in the coming years.
PEG (NY)1.05
PEG (5Y)10.76
EPS Next 2Y52.54%
EPS Next 3Y42.39%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.18%, CCJ is not a good candidate for dividend investing.
CCJ's Dividend Yield is slightly below the industry average, which is at 5.79.
With a Dividend Yield of 0.18, CCJ pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

The dividend of CCJ decreases each year by -7.75%.
CCJ has paid a dividend for at least 10 years, which is a reliable track record.
CCJ has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-7.75%
Div Incr Years0
Div Non Decr Years5

5.3 Sustainability

CCJ pays out 14.43% of its income as dividend. This is a sustainable payout ratio.
DP14.43%
EPS Next 2Y52.54%
EPS Next 3Y42.39%

CAMECO CORP

NYSE:CCJ (4/26/2024, 4:12:01 PM)

After market: 49.49 +0.14 (+0.28%)

49.35

+0.19 (+0.39%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap21.43B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 85.09
Fwd PE 47.22
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.05
PEG (5Y)10.76
Profitability
Industry RankSector Rank
ROA 3.63%
ROE 5.92%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.02%
PM (TTM) 13.94%
GM 21.7%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.55
Quick Ratio 0.97
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)132.35%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y80.91%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)38.53%
Revenue growth 3Y12.86%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y